Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Active versus Passive Immunity01:31

Active versus Passive Immunity

11.8K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
11.8K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Care Encounters by Aboriginal and Torres Strait Islander People Aged 15-24 Years at Urban Aboriginal and Torres Strait Islander Community-Controlled Health Organisations in Southeast Queensland.

Journal of primary care & community health·2026
Same author

Cost-effectiveness of a decentralised molecular point-of-care testing programme for sexually transmitted infections in remote primary care health services in Australia.

Sexually transmitted infections·2026
Same author

Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in Australia.

Sexually transmitted infections·2026
Same author

Priorities to eliminate congenital syphilis in Australia: findings from a national roundtable.

Sexual health·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026

Related Experiment Video

Updated: Mar 12, 2026

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

12.0K

Hepatitis B immunization for indigenous adults, Australia.

Andre Louis Wattiaux1, J Kevin Yin1, Frank Beard1

  • 1National Centre for Immunisation Research and Surveillance, Kerry Packer Building, Children's Hospital at Westmead, corner Hawkesbury Rd and Hainsworth St, Westmead NSW 2145, Australia .

Bulletin of the World Health Organization
|November 9, 2016
PubMed
Summary

Indigenous Australians experience higher rates of hepatitis B infection compared to non-indigenous people. A targeted immunization program could prevent hundreds of new hepatitis B cases annually.

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Related Experiment Videos

Last Updated: Mar 12, 2026

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

12.0K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis B remains a significant public health concern globally.
  • Vaccine-preventable diseases disproportionately affect indigenous populations worldwide.
  • Health inequities persist in Australia regarding infectious disease burden.

Purpose of the Study:

  • To quantify the incidence disparity of hepatitis B between indigenous and non-indigenous Australians.
  • To estimate the impact of a hepatitis B immunization program on indigenous adults.
  • To assess the health equity gap in vaccine-preventable diseases.

Main Methods:

  • Analysis of national hepatitis B notifications from 2005-2012.
  • Estimation of incident infection rates and rate ratios.
  • Projection of immunization program impact using a simulation model.

Main Results:

  • Acute hepatitis B notification rates were significantly higher in indigenous Australians (3.6/100,000) versus non-indigenous (1.1/100,000).
  • The age-standardized notification rate ratio was 4.0, indicating higher incidence in indigenous populations.
  • A 10-year program vaccinating 50% of non-immune indigenous adults could prevent 527-549 acute hepatitis B cases.

Conclusions:

  • Significant health inequity exists for vaccine-preventable hepatitis B between indigenous and non-indigenous Australians.
  • Targeted adult immunization programs can substantially reduce hepatitis B cases in indigenous communities.
  • A low number needed to vaccinate suggests an efficient intervention strategy.